RTP4 Silencing Provokes Tumor-Intrinsic Resistance to Immune Checkpoint Blockade in Colorectal Cancer

Investigators subcutaneously transplanted the MC38 colon cancer cells into C57BL/6 mice, intraperitoneally injected anti-PD-1 antibody, and then isolated immune checkpoint blockade-resistant subclones from the recurrent tumors.